Description: NanoVibronix, Inc. is a medical device company focusing on noninvasive biological response-activating devices that target wound healing and pain therapy. The Company's products include PainShield, WoundShield and UroShield. Its products under development include Renooskin and Endotrachshield. The Company's principal research and development activities are conducted in Israel, through its subsidiary, NanoVibronix (Israel 2003) Ltd. The Company operates in the United States, Europe and India, among others. The PainShield is a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. The Company's WoundShield system is a patch-based therapeutic ultrasound device that facilitates tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation.
Home Page: www.nanovibronix.com
NAOV Technical Analysis
525 Executive Boulevard
Elmsford,
NY
10523
United States
Phone:
914 233 3004
Officers
| Name | Title |
|---|---|
| Mr. Brian M. Murphy | CEO & Director |
| Mr. Stephen R. Brown CPA, CPA | CFO & Accounting Officer |
| Dr. Harold Jacob M.D. | Chief Medical Officer & Director |
| Mr. Amir Rippel | VP of Marketing |
| Mrs. Lindsey Harrison | VP of Sales |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.7176 |
| Price-to-Sales TTM: | 6.4388 |
| IPO Date: | 2017-06-27 |
| Fiscal Year End: | December |
| Full Time Employees: | 12 |